allogeneic human umbilical cord mesenchymal stem cells (Perking University Shenzhen Hospital)

N/A

Report date: 2025/03/28 16:52:01

Base Information

Drug Nameallogeneic human umbilical cord mesenchymal stem cells (Perking University Shenzhen Hospital)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Umbilical cord stem cell therapyCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesPeking University Shenzhen Hospital
China Registration ClassN/A

Develop Information

Active CompaniesPeking University Shenzhen Hospital
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A